China hosts largest-ever SCO summit with focus on security, economy    Israel claims airstrike kills Hamas spokesperson Abu Ubaida    RED IN, ACE – Moharram Bakhoum partner to launch JOYA Residence in New Obour    Egypt targets EGP 144.8bn investment in agriculture, irrigation    Egypt's real estate sector anticipates investment surge following CBE's rate cut    British Embassy in Cairo closes after Egypt removes security barriers    Train derailment in Matrouh kills three, injures 94    Lebanese Prime Minister visits Egypt's Grand Egyptian Museum    Global Forum on Nicotine 2025: Experts Call for Strengthening Scientific Communications to Reduce Tobacco Risks    URGENT: Egypt's central bank cuts key rates by 200 bps    Egypt, Qatar PMs hold cooperation talks    EGP closes higher vs USD on Thursday    Egypt reviews progress on Hurghada Green City sustainable tourism project    Egypt to tighten waste rules, cut rice straw fees to curb pollution    Egypt prepares unified stance ahead of COP30 in Brazil    Egypt recovers collection of ancient artefacts from Netherlands    Egypt harvests 315,000 cubic metres of rainwater in Sinai as part of flash flood protection measures    Fitch Ratings: ASEAN Islamic finance set to surpass $1t by 2026-end    Egypt, Namibia explore closer pharmaceutical cooperation    Renowned Egyptian novelist Sonallah Ibrahim dies at 88    Al-Sisi says any party thinking Egypt will neglect water rights is 'completely mistaken'    Egyptian, Ugandan Presidents open business forum to boost trade    Egypt's Sisi, Uganda's Museveni discuss boosting ties    Egypt's Sisi warns against unilateral Nile measures, reaffirms Egypt's water security stance    Egypt, Huawei explore healthcare digital transformation cooperation    Egypt's Sisi, Sudan's Idris discuss strategic ties, stability    Greco-Roman rock-cut tombs unearthed in Egypt's Aswan    Egypt reveals heritage e-training portal    Sisi launches new support initiative for families of war, terrorism victims    Egypt expands e-ticketing to 110 heritage sites, adds self-service kiosks at Saqqara    Palm Hills Squash Open debuts with 48 international stars, $250,000 prize pool    On Sport to broadcast Pan Arab Golf Championship for Juniors and Ladies in Egypt    Golf Festival in Cairo to mark Arab Golf Federation's 50th anniversary    Germany among EU's priciest labour markets – official data    Paris Olympic gold '24 medals hit record value    A minute of silence for Egyptian sports    Russia says it's in sync with US, China, Pakistan on Taliban    It's a bit frustrating to draw at home: Real Madrid keeper after Villarreal game    Shoukry reviews with Guterres Egypt's efforts to achieve SDGs, promote human rights    Sudan says countries must cooperate on vaccines    Johnson & Johnson: Second shot boosts antibodies and protection against COVID-19    Egypt to tax bloggers, YouTubers    Egypt's FM asserts importance of stability in Libya, holding elections as scheduled    We mustn't lose touch: Muller after Bayern win in Bundesliga    Egypt records 36 new deaths from Covid-19, highest since mid June    Egypt sells $3 bln US-dollar dominated eurobonds    Gamal Hanafy's ceramic exhibition at Gezira Arts Centre is a must go    Italian Institute Director Davide Scalmani presents activities of the Cairo Institute for ITALIANA.IT platform    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



UK scientists worried vaccines may not work on S.African coronavirus variant: ITV
Published in Ahram Online on 04 - 01 - 2021

Scientists are not fully confident that COVID-19 vaccines will work on a new variant of the coronavirus found in South Africa, ITV's political editor said on Monday, citing an unidentified scientific adviser to the British government.
Both Britain and South Africa have discovered new, more infectious variants in the coronavirus in recent weeks that have driven a surge in cases. British Health Secretary Matt Hancock said on Monday he was now very worried about the strand found in South Africa.
Scientists including BioNTech CEO Ugur Sahin and John Bell, Regius Professor of Medicine at the University of Oxford, have said they are testing the vaccines on the new variants and say they could make any required tweaks in around six weeks.
"According to one of the government's scientific advisers, the reason for Matt Hancock's 'incredible worry' about the South African COVID-19 variant is that they are not as confident the vaccines will be as effective against it as they are for the UK's variant," ITV political editor Robert Peston said.
Public Health England said there was currently no evidence to suggest that vaccines will not be effective against the new strain. The health ministry did not immediately respond to requests for comment on the report.
The world's richest countries have started vaccinating their populations to safeguard against a virus that has killed 1.8 million people and crushed the global economy.
There are currently 60 vaccine candidates in trials, including those that are already being rolled out from AstraZeneca and Oxford, Pfizer and BioNTech , Moderna, Russia's Sputnik V and China's Sinopharm.
That has helped to lift global financial markets, but the discovery of the new variants has raised fresh alarm.
Scientists say the new South African variant has multiple mutations in the important "spike" protein that the virus uses to infect human cells.
It has also been associated with a higher viral load, meaning a higher concentration of virus particles in patients' bodies, possibly contributing to higher levels of transmission.
Oxford's Bell, who advises the government's vaccine task force, said on Sunday he thought vaccines would work on the British variant but said there was a "big question mark" as to whether they would work on the South African variant.
He told Times Radio that the shots could be adapted and "it might take a month or six weeks to get a new vaccine".
BioNTech's Sahin told Spiegel in an interview published on Friday that their vaccine, which uses messenger RNA to instruct the human immune system to fight the coronavirus, should be able to cope with the variant first detected in Britain.
"We are testing whether our vaccine can also neutralise this variant and will soon know more," he said.
Asked about coping with a strong mutation, he said it would be possible to tweak the vaccine as required within six weeks - though it might require additional regulatory approvals.


Clic here to read the story from its source.